Clinical Trial Update: Combined Modality Treatment for Patients With Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating combined modality treatment for patients with stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Baylor Research Institute | Conditions: Malignant Melanoma Stage IV | Phase 1, Phase 2 | Status: COMPLETED